---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-056378"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:58:14.238014+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma awards CEO $331k and COO $265k in 2024 cash bonuses

## Summary
- Compensation Committee approved 2024 annual cash bonus of $331,238 for CEO Dr. Michael Myers.
- COO Denise Carter received 2024 annual cash bonus of $264,640.
- Bonuses are consistent with CEO and COO compensation programs approved at Dec 5, 2024 shareholder meeting.

## SEC filing metadata
- accession: 0001104659-25-056378
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465925056378/0001104659-25-056378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925056378/tm2517172d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-056378
- JSON: https://secwatch.observer/filing/0001104659-25-056378.json
- Plain text: https://secwatch.observer/filing/0001104659-25-056378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.